Six Tips for Measuring Hospitalist Program Performance
Nelson suggests having six to 10 measures on a dashboard. According to Martin Buser, MPH, FACHE, founding partner at Hospitalist Management Resources, LLC, a hospitalist consulting firm in Del Mar, CA, those measure should include:
Measure what the CEO measures
Hospitalist leaders should align their program dashboards with the dashboard the CEO presents to the board so that everyone in the boat is rowing in the same direction. For example, if the CEO is measuring readmission rates for the entire hospital, the hospitalist program leader should be measuring readmission rates for the program.
Stick with the same format
Don't present patient satisfaction data using a pie chart one month, a bar graph the next month, and a line graph the next month. "Stick with the same format all the time so people's eyes can quickly fall on the numbers that matter," says Nelson. If it is a three-page report, the first page should always contain the same type of information (i.e., patient satisfaction) as the previous report.
Compare hospitalist program performance to othersBuser recommends that hospitalist program dashboards compare the hospitalist program's performance against the rest of the medical staff and against national benchmarks to tap into their competitive nature. National benchmarking data can be found at Thomson Reuters (www.100TopHospitals.com), Premier, and Volunteer Hospitals of America. In addition, The Society of Hospital Medicine and the Medical Group Management Association will publish this September the 2010 State of Hospital medicine Report based on 2009 Data. Check here for updates.
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- House Calls Key to Pioneer ACO Success
- How Telehealth Pays Off for Providers, Patients
- 4 Tips for Managing Employed Physicians
- Defensive Medicine Still Prevalent Despite Tort Reform
- WellPoint Dominates Nearly Half of Markets, AMA Says
- 'Overtreatment' Debate Circles Back to Lung Cancer Screening